TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Palo Alto Shares Tumble After Company Cuts Full-Year Guidance
Play
JIM CRAMER

'Mad Money' Lightning Round: Oracle, Zillow, Pfizer and more

  • By Scott Rutt
  • Mar 3, 2021 8:02 AM EST
PRESS RELEASES

U.S. FDA Expands Approval Of Pfizer's LORBRENA® As First-Line Treatment For ALK-Positive Metastatic Lung Cancer

  • By Business Wire
  • Mar 3, 2021 7:03 PM EST
Palo Alto Shares Tumble After Company Cuts Full-Year Guidance
JIM CRAMER

'Mad Money' Lightning Round: Oracle, Zillow, Pfizer and more

  • By Scott Rutt
  • Mar 3, 2021 8:02 AM EST
Vaccine Lead
JIM CRAMER

All About Optimism: Cramer's 'Mad Money' Recap (Tuesday 3/2/21)

  • By Scott Rutt
  • Mar 2, 2021 8:48 PM EST
PRESS RELEASES

Strata Oncology Announces The Strata PATH Trial With Pfizer As First Pharma Partner

  • By PR Newswire
  • Mar 2, 2021 7:00 AM EST
Johnson & Johnson's Profits Exceeds Analysts' Expectations
INVESTING

Johnson & Johnson Shares Leap After FDA, CDC Coronavirus Vaccine Approvals

  • By Martin Baccardax
  • Mar 1, 2021 9:54 AM EST
Lufax is set to make the biggest splash on the NYSE by a Chinese company since e-commerce giant Alibaba's IPO in 2014. Photo: Reuters
INVESTING

Dow Futures Surge as Bond Yields Retreat, Vaccine Pace Accelerates; Johnson & Johnson Gets FDA Approval

  • By Martin Baccardax
  • Mar 1, 2021 7:47 AM EST
Cramer: JNJ Deal Will Lead to a Buyback and Much More Upside
LATEST NEWS

CDC Committee OK's Johnson & Johnson COVID Shot

  • By Adam Smith
  • Feb 28, 2021 5:07 PM EST
Faster FDA Approvals of New Drugs Would Lead to Lower Prices, Says Premier CEO
LATEST NEWS

As the FDA Takes Center Stage During COVID, Big Changes Could Be Ahead

  • By Adam Smith
  • Feb 28, 2021 3:14 PM EST
Jerome-Powell
INVESTING

Jim Cramer: What History Tells Us About Bond-Rate Scares Like This

  • By Jim Cramer
  • Mar 1, 2021 7:43 AM EST
Chinese health care firms draw strong IPO investors' demand in Hong Kong. Photo: Shutterstock
LATEST NEWS

Quickly Vaccinating Hong Kong May Be a Long Shot

  • By Adam Smith
  • Feb 28, 2021 3:25 PM EST
J&J Ordered to Pay $572 Million in Oklahoma Opioid Case
INVESTING

Johnson & Johnson's COVID-19 Vaccine Is Cleared by the FDA

  • By Joseph Woelfel
  • Feb 27, 2021 7:34 PM EST
Stocks Open Higher on Positive Earnings from J&J, Coca-Cola
INVESTING

Johnson & Johnson One-Shot Vaccine Wins Advisory Panel OK

  • By Tom Bemis
  • Feb 26, 2021 5:59 PM EST
No More Tears for Johnson & Johnson?
INVESTING

J&J Vaccine May Be Near OK, With Shots to Follow Soon After

  • By Dan Weil
  • Feb 26, 2021 10:14 AM EST
Moderna Lead
INVESTING

Moderna Extends Gains as Jim Cramer Talks About Potential Cancer Vaccine

  • By Martin Baccardax
  • Feb 26, 2021 9:45 AM EST
PRESS RELEASES

European Medicines Agency Accepts Pfizer's Marketing Authorization Application For Its Investigational 20-valent Pneumococcal Conjugate Vaccine For Adults 18 Years Of Age Or Older

  • By Business Wire
  • Feb 26, 2021 6:45 AM EST
PRESS RELEASES

EMA Accepts Marketing Application For Somatrogon To Treat Pediatric Patients With Growth Hormone Deficiency

  • By Business Wire
  • Feb 26, 2021 6:30 AM EST
Moderna Lead
Video

Moderna Says Trials for COVID Variant Boost Shot Have Begun

  • Feb 25, 2021 11:16 AM EST
Moderna Lead
INVESTING

Moderna Fourth-Quarter Sales Boosted by COVID Vaccine Rollout

  • By M. Corey Goldman
  • Feb 25, 2021 11:17 AM EST
PRESS RELEASES

Pfizer And BioNTech Initiate A Study As Part Of Broad Development Plan To Evaluate COVID-19 Booster And New Vaccine Variants

  • By GlobeNewswire
  • Feb 25, 2021 6:45 AM EST
PRESS RELEASES

Pfizer And BioNTech Initiate A Study As Part Of Broad Development Plan To Evaluate COVID-19 Booster And New Vaccine Variants

  • By Business Wire
  • Feb 25, 2021 6:45 AM EST
New York Stock Exchange Traders Lead
MARKETS

Nvidia, GameStop, AMC, Salesforce, Pfizer - 5 Things You Must Know Thursday

  • By Joseph Woelfel
  • Feb 25, 2021 8:51 AM EST
No More Tears for Johnson & Johnson?
INVESTING

Johnson & Johnson COVID Vaccine Gets FDA Support Before Emergency Use Hearing

  • By Martin Baccardax
  • Feb 24, 2021 9:33 AM EST
PRESS RELEASES

Seven Bridges Selected By Pfizer To Support Data Management Solution For Single-Cell RNA Sequencing Data

  • By PR Newswire
  • Feb 24, 2021 8:00 AM EST
PRESS RELEASES

U.S. FDA Accepts For Priority Review Pfizer's Application For TicoVac™ (Tick-borne Encephalitis Vaccine)

  • By Business Wire
  • Feb 23, 2021 4:30 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.